Technology
Health
Pharmaceutical

Constellation Pharmaceuticals

$10.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.17 (1.73%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CNST and other stocks, options, ETFs, and crypto commission-free!

About CNST

Constellation Pharmaceuticals, Inc. Common Stock, also called Constellation Pharmaceuticals, is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. Read More The company utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product candidates include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA.

Employees
82
Headquarters
Cambridge, Massachusetts
Founded
2008
Market Cap
253.68M
Price-Earnings Ratio
Dividend Yield
Average Volume
75.50K
High Today
$10.53
Low Today
$9.78
Open Price
$9.85
Volume
41.72K
52 Week High
$14.04
52 Week Low
$4.01

Collections

Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
Therapy
2018 IPO
US

CNST Earnings

-$9.96
-$6.88
-$3.79
-$0.71
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.